Aehr Test Systems (NASDAQ:AEHR – Get Free Report) EVP Alberto Salamone sold 9,672 shares of the company’s stock in a transaction on Thursday, August 13th. The shares were sold at an average price of $127.72, for a total transaction of $1,235,307.84. Following the completion of the sale, the executive vice president owned 41,962 shares of the company’s stock, valued at approximately $5,359,386.64. This trade represents a 18.73% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website.
Aehr Test Systems Stock Performance
Aehr Test Systems stock traded up $8.83 during midday trading on Friday, hitting $132.13. 2,838,105 shares of the company’s stock were exchanged, compared to its average volume of 2,433,361. The stock has a market cap of $4.31 billion, a price-to-earnings ratio of -551.21 and a beta of 3.10. Aehr Test Systems has a 12-month low of $16.38 and a 12-month high of $147.40. The firm’s 50 day simple moving average is $92.12 and its 200 day simple moving average is $71.00.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of AEHR. BlackRock Inc. acquired a new stake in shares of Aehr Test Systems in the second quarter valued at about $255,476,000. Vanguard Group Inc. grew its holdings in shares of Aehr Test Systems by 2.2% in the 4th quarter. Vanguard Group Inc. now owns 2,337,433 shares of the semiconductor company’s stock worth $47,193,000 after acquiring an additional 49,243 shares during the period. Wellington Management Group LLP raised its holdings in Aehr Test Systems by 129.9% during the fourth quarter. Wellington Management Group LLP now owns 830,664 shares of the semiconductor company’s stock worth $16,771,000 after purchasing an additional 469,400 shares during the last quarter. Geode Capital Management LLC raised its holdings in Aehr Test Systems by 0.8% during the fourth quarter. Geode Capital Management LLC now owns 685,694 shares of the semiconductor company’s stock worth $13,846,000 after purchasing an additional 5,591 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Aehr Test Systems in the second quarter valued at $64,433,000. Institutional investors and hedge funds own 69.69% of the company’s stock.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on AEHR
Aehr Test Systems News Summary
Here are the key news stories impacting Aehr Test Systems this week:
- Positive Sentiment: A fresh Wall Street initiation helped drive renewed buying interest. The analyst reportedly viewed the price target as conservative and did not include several potential catalysts, suggesting possible upside if AI-related demand continues to expand. Aehr Test Systems Soars Again
- Positive Sentiment: Aehr’s $22 million follow-on order from its lead customer reinforces demand for its FOX wafer-level burn-in systems used with advanced AI processors. Record bookings of $60.7 million, a roughly $100.6 million backlog and fiscal 2027 revenue guidance of $130 million to $150 million improve visibility into future growth. Aehr’s AI Order and WLBI Opportunity
- Neutral Sentiment: CEO Gayn Erickson and CFO Chris Siu will meet investors at the Needham Virtual Semiconductor and SemiCap 1×1 Conference on August 19. The event could provide updates on AI demand, backlog conversion and fiscal 2027 execution, but no new financial data was announced. Aehr to Participate in Needham Conference
- Negative Sentiment: Insiders sold approximately 65,130 shares worth $8.5 million on August 12. The sales included 40,000 shares by CEO Gayn Erickson, 15,000 by COO Adil Engineer and shares by two directors. Erickson’s shares came from an indirectly held trust and his direct position was unchanged, while the other insiders retained sizable holdings; nevertheless, the transactions may signal profit-taking after AEHR’s sharp advance and could add selling pressure. Aehr CEO Stock Sale Filing
- Negative Sentiment: After gaining more than 500% over the past year, AEHR’s valuation reflects very high expectations. Its negative earnings multiple leaves the stock vulnerable if AI orders slow, backlog conversion disappoints or fiscal 2027 execution falls short.
About Aehr Test Systems
Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.
The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.
Recommended Stories
- Five stocks we like better than Aehr Test Systems
- Sony and TSMC’s $4.7 Billion Venture Is About More Than Camera Sensors
- Quantum Leaps: Debt-Free as AI Storage Demand Accelerates
- NVIDIA’s $500 Billion GPU Financing Deal Fuels Path Toward $270
- Sandisk’s Margins Look Like Software. Can They Last?
Receive News & Ratings for Aehr Test Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aehr Test Systems and related companies with MarketBeat.com's FREE daily email newsletter.
